Kerala Ayurveda Not a 'Large Corp' Due to ₹70 Cr Debt

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Kerala Ayurveda Not a 'Large Corp' Due to ₹70 Cr Debt
Overview

Kerala Ayurveda Ltd. has stated it does not meet the 'Large Corporate' criteria under SEBI's debt issuance rules. With outstanding borrowing at ₹70.47 crore as of March 31, 2026, the company is below the threshold, clarifying its compliance for fundraising.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Kerala Ayurveda Limited has officially informed the Bombay Stock Exchange that it does not meet the criteria to be classified as a 'Large Corporate' under SEBI regulations. The company's outstanding borrowing stood at ₹70.47 crore as of March 31, 2026, a figure significantly below SEBI's thresholds. This clarification means Kerala Ayurveda is not subject to the specific compliance obligations mandated for 'Large Corporates' under SEBI's framework for fundraising via debt securities.

The SEBI 'Large Corporate' framework aims to deepen India's corporate bond market by requiring eligible companies to raise a significant portion of their debt through listed debt securities. By clarifying its status, Kerala Ayurveda offers investors transparency regarding its regulatory standing and debt financing approach, avoiding potential confusion.

SEBI introduced the 'Large Corporate' (LC) framework to encourage broader participation in India's corporate debt market. Initially, LCs were defined by listed securities, ₹100 crore or more in long-term borrowings, and an 'AA' or higher credit rating. A revised framework, effective April 1, 2024, raised the borrowing threshold to ₹1,000 crore while maintaining the 'AA' rating requirement. Under the current rules, identified LCs must raise at least 25% of qualified borrowings via debt securities over a three-year period.

This clarification officially confirms Kerala Ayurveda's status as a non-'Large Corporate'. Consequently, the company is exempt from the specific disclosure and fundraising mandates for 'Large Corporates' under SEBI's debt issuance framework. This provides clear information to stakeholders regarding the company's compliance and financial strategy.

No specific risks related to this status clarification were identified in the company's filing.

This announcement is a company-specific regulatory clarification and does not lend itself to direct peer comparison.

As of March 31, 2026, Kerala Ayurveda's outstanding borrowing was ₹70.47 crore.

What to track next:

  • Future announcements from Kerala Ayurveda regarding its borrowing plans or changes in debt levels.
  • Any updates or modifications to SEBI's 'Large Corporate' framework.
  • Kerala Ayurveda's overall financial performance and its ability to maintain its credit profile.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.